All In MedTech

Company

Eurosets

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Eurosets, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Eurosets.

Latest FDA decisions

Search the Clearance Tracker

3 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07354841 · 80 participants (planned) · Start Oct 21, 2025 · Primary completion Sep 30, 2026

    Device: Eurosets Venous and Arterial Cannula; Control Arterial and Venous Cannulas · For: Cardiac Surgery; Heart Surgery; Cardiopulmonary Bypass and 6 more

    Sites: Bari, Italy

  • NCT07087639 · 42 participants · Start Dec 22, 2022 · Primary completion Feb 5, 2025

    Device: Self-expanding Venous Cannula · For: Cardiac Surgery; Heart Surgery; Cardiopulmonary Bypass and 1 more

    Sites: Cotignola, Italy

  • NCT05163925 · 30 participants (planned) · Start Jan 10, 2022 · Primary completion Jul 2025

    Device: Eurosets ECMO Life System · For: Extracorporeal Membrane Oxygenation Complication

    Sites: Vienna, Austria

Reports received

72

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

53

74% of reports

Injury reports

16

22% of reports

Death reports

3

4.2% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 235000
Jan 241100
Feb 244210
Mar 245000
Apr 246000
May 242000
Jun 242100
Jul 243010
Aug 243100
Sep 242000
Oct 242000
Nov 242100
Dec 243000
Jan 254000
Feb 256000
Mar 253100
Apr 251300
May 252000
Jun 253100
Jul 257000
Aug 252000
Sep 251000
Oct 253000
Nov 2511100
Dec 256210
Jan 264010
Feb 261000
Mar 264200
Apr 265200
May 260100
Jun 263600
Jul 262000
Aug 269000
Sep 263100
Oct 265110
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.